JP2014503581A - 膣感染症を処置するため膣適用において使用するための固体形態にある発泡組成物 - Google Patents
膣感染症を処置するため膣適用において使用するための固体形態にある発泡組成物 Download PDFInfo
- Publication number
- JP2014503581A JP2014503581A JP2013550962A JP2013550962A JP2014503581A JP 2014503581 A JP2014503581 A JP 2014503581A JP 2013550962 A JP2013550962 A JP 2013550962A JP 2013550962 A JP2013550962 A JP 2013550962A JP 2014503581 A JP2014503581 A JP 2014503581A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- lactobacillus
- acid
- present
- bicarbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
本発明は、膣感染症を処置するため膣適用に使用するための固体形態にある発泡組成物に関する。腸および泌尿生殖器の微生物叢の構成は、個人の健康および満足のいく生活にとって重要であることがよく知られている。膣環境体系は、膣および子宮をつなぐ上皮細胞、臓器内腔中に分泌する腺細胞および様々な微生物種により構成される複雑な細菌叢からなる。
好ましい実施形態において、細菌株は、Lactobacillus salivarius CRL 1328、Lactobacillus paracasei CRL 1289、Lactobacillus gasseri CRL 1259、Lactobacillus crispatus CRL 1251、Lactobacillus crispatus CRL 1266、Lactobacillus acidphilus CRL 1294、Lactobacillus paracasei LPC 00、Lactobacillus plantarum LP 02 および Lactobacillus fermentum LF 10、から選択される。
表3は、25℃で貯蔵2年後の、行使した様々な圧力のプロバイオティクス細菌(表2に示す組成物)の死亡率データおよび錠剤安定性(担持細菌の半減期として表す)を示す。
(1)生存細胞数1x109CFU/0時点で予測される粉末のg
(2)生存細胞数1x109CFU/0時点で存在する粉末のg
(3)圧縮による死亡率%
(4)生存細胞数1x109CFU/25℃で2年後の錠剤
(5)半減期の日数。
Claims (10)
- 下記のもの:
−有機酸、ならびに炭酸および/または重炭酸アニオンの塩を含む酸-塩基系、
該塩は、該組成物の全重量に対して1〜15重量%の量で存在している;
−微晶質セルロースおよびアラビノガラクタンを含む混合物;
−Candida albicans、Candida glabrata、Candida parapsilosis、Candida krusei、Candida tropicalis、Gardnerella vaginalis、Trichomonas vaginalis、Neisseria gonorrhoeae、Escherichia coli、Herpes simplex および Haemophilus ducreyi を含む群から選択される、病原性物質の存在を減少および/または除去する能力を有する少なくとも1つのプロバイオティクス細菌株;
を含む、膣感染症を処置するため膣適用において使用するための固体形態にある発泡組成物。 - 錠剤、膣用坐剤(ovule)、ロゼンジまたは顆粒の形態にある、請求項1に記載の使用のための組成物。
- 有機酸が、クエン酸、リンゴ酸、酒石酸、フマル酸、乳酸およびその混合物からなる群から選択され、好ましくは、有機酸がクエン酸である、請求項1または2に記載の使用のための組成物。
- 炭酸および/または重炭酸アニオンの塩が、炭酸ナトリウム、炭酸カリウム、炭酸カルシウム、炭酸マグネシウム、ナトリウムグリシン炭酸塩、重炭酸ナトリウム、重炭酸カリウム、重炭酸カルシウム、重炭酸マグネシウム、乳酸ナトリウム、乳酸カリウム、炭酸塩、乳酸塩およびその混合物からなる群から選択され、好ましくは重炭酸アニオンの塩である、請求項1〜3のいずれか1項に記載の使用のための組成物。
- 炭酸および/または重炭酸アニオンの塩が、該組成物の全重量に対して、3〜13重量%の量で存在し、好ましくは該組成物の全重量に対して、4〜12重量%の量で存在し、さらにより好ましくは該組成物の全重量に対して、5〜10重量%の量で存在している、請求項5に記載の使用のための組成物。
- 酸-塩基系が、重炭酸ナトリウムおよびクエン酸からなり、該重炭酸ナトリウムは、該組成物の全重量に対して、3〜13重量%の量で存在し、好ましくは該組成物の全重量に対して、4〜12重量%の量で存在し、さらにより好ましくは該組成物の全重量に対して、5〜10重量%の量で存在する、請求項1〜5のいずれか1項に記載の使用のための組成物。
- 微晶質セルロースおよびアラビノガラクタンが、1:1〜3:1の重量比で存在する、請求項1に記載の使用のための組成物。
- 少なくとも1つのプロバイオティクス細菌株が、Lactobacillus plantarum、Lactobacillus pentosus、Lactobacillus casei、Lactobacillus casei ssp.paracasei、Lactobacillus rhamnosus、Lactobacillus acidophilus、Lactobacillus delbrueckii、Lactobacillus delbrueckii ssp. bulgaricus、Lactobacillus delbrueckii ssp.delbrueckii、Lactobacillus fermentum、Lactobacillus gasseri、Lactobacillus reuteri、Bifidobacterium longum、Bifidobacterium bifidum、Bifidobacterium breve、Bifidobacterium animalis ssp. lactis、Bifidobacterium adolescentis、Bifidobacterium pseudocatenulatum、Bifidobacterium catenulatum および Bifidobacterium infantis からなる群から選択される少なくとも1つの種に属しており、該少なくとも1つの細菌株が、好ましくはLactobacillus salivarius CRL 1328、Lactobacillus paracasei CRL 1289、Lactobacillus gasseri CRL 1259、Lactobacillus crispatus CRL 1251、Lactobacillus crispatus CRL 1266、Lactobacillus acidophilus CRL 1294、Lactobacillus paracasei LPC 00、Lactobacillus plantarum LP 02 または Lactobacillus fermentum LF 10 の中から選択される、請求項1〜7のいずれか1項に記載の使用のための組成物。
- 膣炎、膣症、カンジタ症、淋病、ヘルペスおよび性病性潰瘍の処置のためのものである、請求項1〜8のいずれか1項に記載の使用のための組成物。
- 下記のもの:
−重炭酸ナトリウムおよびクエン酸を含む酸-塩基系、
該重炭酸塩は、該組成物の全重量に対して、1〜15重量%の量で存在している;
−微晶質セルロースおよびアラビノガラクタンを、1:1〜3:1の重量比で含む混合物;
−Candida albicans、Candida glabrata、Candida parapsilosis、Candida krusei、Candida tropicalis、Gardnerella vaginalis、Trichomonas vaginalis、Neisseria gonorrhoeae、Escherichia coli、Herpes simplex および Haemophilus ducreyi を含む群から選択される、病原物質の存在を減少および/または除去する能力を有する少なくとも1つのプロバイオティクス細菌株;
を含む、膣感染症を処置するため膣適用において使用するための固体形態にある発泡組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2011A000107 | 2011-01-28 | ||
ITMI2011A000107A IT1403661B1 (it) | 2011-01-28 | 2011-01-28 | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
IT000316A ITMI20110316A1 (it) | 2011-01-28 | 2011-03-01 | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
ITMI2011A000316 | 2011-03-01 | ||
PCT/IB2012/000095 WO2012101500A1 (en) | 2011-01-28 | 2012-01-24 | Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014503581A true JP2014503581A (ja) | 2014-02-13 |
JP2014503581A5 JP2014503581A5 (ja) | 2015-05-14 |
JP5992446B2 JP5992446B2 (ja) | 2016-09-14 |
Family
ID=43975441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013550962A Expired - Fee Related JP5992446B2 (ja) | 2011-01-28 | 2012-01-24 | 膣感染症を処置するため膣適用において使用するための固体形態にある発泡組成物 |
Country Status (22)
Country | Link |
---|---|
US (2) | US9492377B2 (ja) |
EP (1) | EP2667849B1 (ja) |
JP (1) | JP5992446B2 (ja) |
KR (1) | KR101913797B1 (ja) |
CN (1) | CN104519866A (ja) |
AU (1) | AU2012210296B2 (ja) |
BR (1) | BR112013018953B1 (ja) |
CL (1) | CL2013002148A1 (ja) |
CO (1) | CO6771428A2 (ja) |
DK (1) | DK2667849T3 (ja) |
EC (1) | ECSP13012844A (ja) |
ES (1) | ES2751416T3 (ja) |
IT (2) | IT1403661B1 (ja) |
MA (1) | MA34926B1 (ja) |
MX (1) | MX347165B (ja) |
PE (2) | PE20140259A1 (ja) |
PL (1) | PL2667849T3 (ja) |
PT (1) | PT2667849T (ja) |
RU (1) | RU2587717C2 (ja) |
TN (1) | TN2013000310A1 (ja) |
UA (1) | UA114888C2 (ja) |
WO (1) | WO2012101500A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018522919A (ja) * | 2015-08-13 | 2018-08-16 | プロバイオティカル・ソシエタ・ペル・アチオニProbiotical S.P.A. | プロピオニバクテリウム・アクネス(Propionibacterium acnes)による感染症、特にざ瘡の処置に使用するための乳酸菌の組成物 |
JP2019509312A (ja) * | 2016-03-24 | 2019-04-04 | プロバイオティカル・エッセ・ピ・ア | ガードネレラ・バギナリスによる細菌腟感染症及び存在する場合には併発真菌感染症を治療するための乳酸菌組成物 |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1403661B1 (it) | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
ITMI20130794A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche. |
ITMI20130795A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat |
TWI643626B (zh) * | 2013-08-12 | 2018-12-11 | 西班牙商巨妮亞實驗室有限公司 | 作為益生菌之乳桿菌屬菌株 |
JP6990922B2 (ja) | 2015-05-11 | 2022-01-12 | マイバイオティクス ファーマ リミテッド | 腸における細菌のコロニー形成のために固体粒子上で生菌のバイオフィルムを成長させるためのシステムおよび方法 |
KR101980252B1 (ko) | 2015-05-26 | 2019-05-21 | (주)투라인스 | 질증 치료용 조성물 |
MX2018002533A (es) * | 2015-09-29 | 2018-06-27 | Kimberly Clark Co | Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora. |
CN105534948B (zh) * | 2015-12-17 | 2019-05-03 | 内蒙古双奇药业股份有限公司 | 一种可常温保存的阴道用活菌制剂及其制备方法 |
ITUB20159330A1 (it) * | 2015-12-22 | 2017-06-22 | Roelmi Hpc S R L | Composizioni probiotiche e loro uso |
BE1023643B1 (nl) * | 2016-03-21 | 2017-06-01 | Yun NV | Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota |
CA3018035A1 (en) * | 2016-03-24 | 2017-09-28 | Probiotical S.P.A. | Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections |
WO2017184619A2 (en) * | 2016-04-18 | 2017-10-26 | Celldex Therapeutics, Inc. | Agonistic antibodies that bind human cd40 and uses thereof |
RU2022101485A (ru) | 2016-05-25 | 2022-04-27 | Майбиотикс Фарма Лтд. | Композиция и способы для микробиотной терапии |
US11026883B2 (en) | 2016-10-13 | 2021-06-08 | Catalent U.K. Swindon Zydis Limited | Lyophilized pharmaceutical compositions for vaginal delivery |
CN106798755B (zh) * | 2017-03-10 | 2020-09-15 | 山东神农医院管理有限公司 | 一种具有调理乳腺增生功能的益生菌组合物及其应用 |
CN106692204B (zh) * | 2017-03-10 | 2020-05-22 | 泰安大凡神农生物有限公司 | 一种缓解或改善盆腔炎症的益生菌组合物及其制备方法 |
KR102014810B1 (ko) * | 2017-09-04 | 2019-08-27 | 라임바이오파마 주식회사 | 질염 예방 및 치료용 조성물 |
TWI703991B (zh) * | 2017-09-29 | 2020-09-11 | 榮華 曹 | 供給二氧化碳氣體的衛生用品 |
IT201800020425A1 (it) | 2018-12-20 | 2020-06-20 | Univ Degli Studi Di Modena E Reggio Emilia | Lattobacilli con attività antimicrobica |
CN109846846A (zh) * | 2018-12-20 | 2019-06-07 | 赛奈金生物科技(上海)有限公司 | 一种含益生菌的泡腾缓释剂及其制备方法和应用 |
CN109740292A (zh) * | 2019-01-30 | 2019-05-10 | 中国测绘科学研究院 | 一种基于多智能体的城市人口空间分布估算方法及装置 |
US11045507B2 (en) | 2019-02-21 | 2021-06-29 | Ewelina Sosnowska-Turek | Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30 |
KR102063757B1 (ko) * | 2019-05-03 | 2020-01-08 | 주식회사 메디오젠 | 가드네렐라 바기날리스 및 칸디다 알비칸스에 항균 효과를 갖는 질염 치료 또는 개선용 유산균 |
CN110547915A (zh) * | 2019-08-29 | 2019-12-10 | 云南白药清逸堂实业有限公司 | 应用益生菌的卫生棉制品及其制备方法 |
CN111647525B (zh) * | 2020-05-18 | 2022-08-05 | 深圳华大基因农业控股有限公司 | 复合益生菌、菌剂及其在制备防治白色念珠菌性阴道炎菌剂中的应用 |
KR102444746B1 (ko) * | 2021-09-16 | 2022-09-19 | 일동바이오사이언스(주) | 락토바실러스 카제이 idcc 3451을 포함하는 질염에 유용한 조성물 |
KR20230068336A (ko) * | 2021-11-08 | 2023-05-17 | 주식회사 씨티씨바이오 | 질염 또는 요로감염증 유발 미생물에 항균활성을 지닌 유산균 및 그의 용도 |
CN114350576B (zh) * | 2022-03-17 | 2022-06-07 | 烟台欣和企业食品有限公司 | 提高料酒抗风险能力的乳杆菌及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1345589A (zh) * | 2000-09-28 | 2002-04-24 | 上海信谊药业有限公司 | 含嗜酸乳杆菌的药物制剂及制备方法 |
JP2010511033A (ja) * | 2006-11-28 | 2010-04-08 | プロバイオティカル エス.ピー.エイ. | 婦人科および直腸科分野における生物活性成分投与のための組成物とその使用方法 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3819838A (en) | 1970-08-04 | 1974-06-25 | Bush Boake Allen Ltd | Encapsulated flavoring composition |
JPS53121949A (en) | 1977-03-31 | 1978-10-24 | Yakult Honsha Kk | Production of drink and food containing bifidobacterium cells |
DE2757370A1 (de) | 1977-12-22 | 1979-07-05 | Bayer Ag | Gasdichte kunststoff-aluminium-verbundfolien |
CH637297A5 (fr) | 1978-12-05 | 1983-07-29 | Nestle Sa | Microbille comprenant un microorganisme et son procede de fabrication. |
JPS58152809A (ja) * | 1982-03-05 | 1983-09-10 | Eisai Co Ltd | 安定な発泡性「膣」坐剤 |
US4670272A (en) | 1985-11-08 | 1987-06-02 | Frito-Lay, Inc. | Thermostable creme |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
CN1211188A (zh) * | 1996-02-14 | 1999-03-17 | 普罗克特和甘保尔公司 | 用于泌尿生殖道和肠道疾病的组合物 |
EP0845350A1 (de) | 1996-11-29 | 1998-06-03 | Alusuisse Technology & Management AG | Kalt-verformbare Verbundfolie |
ATE314858T1 (de) | 1998-04-01 | 2006-02-15 | Ganeden Biotech Inc | Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen |
EP0956858B1 (en) * | 1998-04-30 | 2001-10-31 | Renata Maria Anna Cavaliere Vesely | Pharmaceutical compositions containing Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections |
RU2150268C1 (ru) | 1998-12-25 | 2000-06-10 | Быков Валерий Алексеевич | Суппозиторий с лактобактериями для лечения дисбактериозов влагалища |
IT1309427B1 (it) | 1999-05-28 | 2002-01-23 | Mendes S U R L | Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso |
WO2004101770A1 (en) | 2003-03-13 | 2004-11-25 | Universite De Moncton (Bureau De Soutien A L'innovation) | Antioxidant producing bacterium and uses thereof |
US20040185032A1 (en) | 2003-03-18 | 2004-09-23 | David Burrell | Compositions and methods for treating colic |
AU2004228759B2 (en) * | 2003-04-09 | 2010-04-08 | Dolhay Klinika Egeszsegugyi Kft. | Sexual hygienic composition |
EP2033529B1 (en) | 2003-10-24 | 2019-12-11 | N.V. Nutricia | Synbiotic composition for infants |
DE50300325D1 (de) | 2003-11-03 | 2005-03-31 | Peter-Hansen Volkmann | Vaginalpflegezusammensetzung |
GB0330009D0 (en) * | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
GB0405406D0 (en) | 2004-03-10 | 2004-04-21 | Edko Pazarlama Tanitim Ltd Sti | Anti-vaginitis compositions |
EP1600060A1 (en) | 2004-05-25 | 2005-11-30 | Cognis IP Management GmbH | Oral and/or topical compositions comprising prebiotics and fatty acid |
DE602004027120D1 (de) | 2004-05-25 | 2010-06-24 | Cognis Ip Man Gmbh | Orale und/oder topische Zubereitungen |
US8168171B2 (en) | 2004-08-05 | 2012-05-01 | Probiotical S.P.A. | Folic acid producing bifidobacterium bacterial strains, formulations and use thereof |
US20060039973A1 (en) * | 2004-08-19 | 2006-02-23 | Mary Aldritt | Effervescent composition including water soluble dietary fiber |
WO2006047680A2 (en) | 2004-10-27 | 2006-05-04 | North Carolina State University | Lactobacillus acidophilus nucleic acids and uses thereof |
KR100661032B1 (ko) | 2005-04-19 | 2006-12-22 | 주식회사한국야쿠르트 | 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물 |
WO2007100765A2 (en) | 2006-02-28 | 2007-09-07 | Childrens Memorial Hospital | Lysozyme-modified probiotic components and uses thereof |
RU2318523C2 (ru) | 2006-03-13 | 2008-03-10 | Лев Давидович Раснецов | Средство антимикробного действия |
EP2269465A1 (en) | 2006-05-03 | 2011-01-05 | Probiotical S.p.a. | Compositions comprising Bifidobacterium adolescentis |
ITMI20061841A1 (it) | 2006-09-27 | 2008-03-28 | Mofin S R L | Colture liquide microbiche ad elevata stabilita' ed attivita' fermentativa |
US20080175899A1 (en) | 2007-01-19 | 2008-07-24 | Ross Mairi R | Formulation for promoting sinus health in nasal cavities |
US20080187628A1 (en) | 2007-02-02 | 2008-08-07 | Champion Melinda L | Water-Soluble, Quick-Dissolve Flavor Tablets |
PL210465B1 (pl) | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
WO2008153377A1 (en) | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
DE102008023952A1 (de) | 2008-05-16 | 2009-12-03 | Alcan Technology & Management Ag | Verpackungs-Deckfolie, Behältnis, Verpackung und Verpackungs-Produkt-Einheit |
CN102124097B (zh) | 2008-08-28 | 2013-11-06 | 科.汉森有限公司 | 细菌组合物 |
US9283252B2 (en) | 2008-09-30 | 2016-03-15 | Meiji Co., Ltd. | Lactic acid bacterium having high oxalic acid decomposition ability |
EP2403510B1 (en) | 2009-03-05 | 2020-02-26 | Probiotical S.p.A. | Bacteria strains having a high anti-inflammatory activity |
IT1400821B1 (it) | 2009-03-09 | 2013-07-02 | Probiotical Spa | Sospensione oleosa contenente batteri probiotici per uso pediatrico |
FI20095550A0 (fi) | 2009-05-19 | 2009-05-19 | Bayer Schering Pharma Oy | Vaginaalinen antojärjestelmä |
IT1397566B1 (it) | 2009-05-27 | 2013-01-16 | Probiotical Spa | Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso |
JP5873018B2 (ja) | 2009-07-27 | 2016-03-01 | ネステク ソシエテ アノニム | 繊維及びプロバイオティクスを含む栄養組成物 |
WO2011012932A1 (en) | 2009-07-30 | 2011-02-03 | Compagnie Gervais Danone | Use of coated sterol or stanol particles for the preparation of food compositions having a low fat content and being essentially emulsifier-free |
IT1398553B1 (it) | 2010-03-08 | 2013-03-01 | Probiotical Spa | Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. |
UA107711C2 (en) | 2010-06-28 | 2015-02-10 | Probiotical Spa | Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic |
IT1403661B1 (it) | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
ITRM20110475A1 (it) | 2011-09-09 | 2013-03-10 | Probiotical Spa | Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e |
-
2011
- 2011-01-28 IT ITMI2011A000107A patent/IT1403661B1/it active
- 2011-03-01 IT IT000316A patent/ITMI20110316A1/it unknown
-
2012
- 2012-01-24 PL PL12706669T patent/PL2667849T3/pl unknown
- 2012-01-24 EP EP12706669.4A patent/EP2667849B1/en active Active
- 2012-01-24 WO PCT/IB2012/000095 patent/WO2012101500A1/en active Application Filing
- 2012-01-24 PT PT127066694T patent/PT2667849T/pt unknown
- 2012-01-24 MX MX2013008547A patent/MX347165B/es active IP Right Grant
- 2012-01-24 AU AU2012210296A patent/AU2012210296B2/en not_active Ceased
- 2012-01-24 ES ES12706669T patent/ES2751416T3/es active Active
- 2012-01-24 KR KR1020137022730A patent/KR101913797B1/ko active IP Right Grant
- 2012-01-24 US US13/982,255 patent/US9492377B2/en active Active
- 2012-01-24 JP JP2013550962A patent/JP5992446B2/ja not_active Expired - Fee Related
- 2012-01-24 UA UAA201309615A patent/UA114888C2/uk unknown
- 2012-01-24 PE PE2013001708A patent/PE20140259A1/es active IP Right Grant
- 2012-01-24 CN CN201280015994.3A patent/CN104519866A/zh active Pending
- 2012-01-24 BR BR112013018953-3A patent/BR112013018953B1/pt not_active IP Right Cessation
- 2012-01-24 DK DK12706669T patent/DK2667849T3/da active
- 2012-01-24 RU RU2013137656/15A patent/RU2587717C2/ru active
- 2012-01-24 PE PE2018000014A patent/PE20180413A1/es not_active Application Discontinuation
-
2013
- 2013-07-23 TN TNP2013000310A patent/TN2013000310A1/fr unknown
- 2013-07-26 CL CL2013002148A patent/CL2013002148A1/es unknown
- 2013-08-06 CO CO13187466A patent/CO6771428A2/es unknown
- 2013-08-20 EC ECSP13012844 patent/ECSP13012844A/es unknown
- 2013-08-27 MA MA36208A patent/MA34926B1/fr unknown
-
2016
- 2016-09-14 US US15/265,706 patent/US20170014335A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1345589A (zh) * | 2000-09-28 | 2002-04-24 | 上海信谊药业有限公司 | 含嗜酸乳杆菌的药物制剂及制备方法 |
JP2010511033A (ja) * | 2006-11-28 | 2010-04-08 | プロバイオティカル エス.ピー.エイ. | 婦人科および直腸科分野における生物活性成分投与のための組成物とその使用方法 |
Non-Patent Citations (1)
Title |
---|
JPN6015047703; AAPS PharmSciTech Vol.8, No.4, 2007, p. Article 109 E1-E8 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018522919A (ja) * | 2015-08-13 | 2018-08-16 | プロバイオティカル・ソシエタ・ペル・アチオニProbiotical S.P.A. | プロピオニバクテリウム・アクネス(Propionibacterium acnes)による感染症、特にざ瘡の処置に使用するための乳酸菌の組成物 |
JP2019509312A (ja) * | 2016-03-24 | 2019-04-04 | プロバイオティカル・エッセ・ピ・ア | ガードネレラ・バギナリスによる細菌腟感染症及び存在する場合には併発真菌感染症を治療するための乳酸菌組成物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5992446B2 (ja) | 膣感染症を処置するため膣適用において使用するための固体形態にある発泡組成物 | |
EP2996701B1 (en) | Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of bacterial vaginosis | |
JP2014503581A5 (ja) | ||
JP2010511033A (ja) | 婦人科および直腸科分野における生物活性成分投与のための組成物とその使用方法 | |
AU2003258366A1 (en) | Probiotic bacterium: lactobacillus fermentum | |
US20200078422A1 (en) | Oral dosage form | |
EP2158916A1 (en) | Administration unit comprising lactic acid bacteria | |
CN117357468B (zh) | 一种可长期储存的益生菌凝胶制剂及其使用方法和应用 | |
US20200155621A1 (en) | Mucoadhesive sustained-release vaginal tablet | |
ITMI20070452A1 (it) | Compressa comprendente microrganismi ed una combinazione di eccipienti e relativo procedimento di produzione | |
JP2019509312A (ja) | ガードネレラ・バギナリスによる細菌腟感染症及び存在する場合には併発真菌感染症を治療するための乳酸菌組成物 | |
US20240066078A1 (en) | Strains, compositions and methods of use | |
Fazeli et al. | Viability of Lactobacillus acidophilus in various vaginal tablet formulations | |
NZ614002B2 (en) | Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections | |
Johannsen | Urogenital infections and probiotics | |
AU2021416723A9 (en) | Strains, compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20141215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150123 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150123 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20150326 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151201 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160225 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160322 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160531 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160726 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160817 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5992446 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |